Patents by Inventor Christopher Mount

Christopher Mount has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC ANTIGEN RECEPTORS WITH CD2 ACTIVATION
    Publication number: 20230183312
    Abstract: Disclosed are chimeric antigen receptors comprising a CD2 co-stimulatory domain that retain function against CD58? and CD58low tumor cells, and CD2 co-stimulatory receptors that promote CAR function against CD58? and CD58low tumor cells.
    Type: Application
    Filed: February 12, 2021
    Publication date: June 15, 2023
    Inventors: Robbie G. MAJZNER, Crystal L. MACKALL, Aidan TOUSLEY, Michelle MONJE-DEISSEROTH, Louai LABANIEH, Christopher MOUNT
  • COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS HARBORING AN H3K27M MUTATION
    Publication number: 20230054466
    Abstract: The invention relates to immunotherapeutic treatment of cancer. In particular, the invention relates to methods of treating cancer carrying a histone H3 K27M (H3K27M) mutation (e.g., diffuse midline glioma with H3K27M mutation) using immunotherapeutic compositions comprising immune cells engineered to express GD2-specific chimeric antigen receptors.
    Type: Application
    Filed: July 26, 2022
    Publication date: February 23, 2023
    Inventors: Michelle Monje-Deisseroth, Robbie Majzner, Crystal Mackall, Christopher Mount
  • Compositions and methods for treatment of cancers harboring an H3K27M mutation
    Patent number: 11433098
    Abstract: The invention relates to immunotherapeutic treatment of cancer. In particular, the invention relates to methods of treating cancer carrying a histone H3K27M (H3K27M) mutation (e.g., diffuse midline glioma with H3K27M mutation) using immunotherapeutic compositions comprising immune cells engineered to express GD2-specific chimeric antigen receptors.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: September 6, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Michelle Monje-Deisseroth, Robbie Majzner, Crystal Mackall, Christopher Mount
  • COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS HARBORING AN H3K27M MUTATION
    Publication number: 20210137979
    Abstract: The invention relates to immunotherapeutic treatment of cancer. In particular, the invention relates to methods of treating cancer carrying a histone H3K27M (H3K27M) mutation (e.g., diffuse midline glioma with H3K27M mutation) using immunotherapeutic compositions comprising immune cells engineered to express GD2-specific chimeric antigen receptors.
    Type: Application
    Filed: July 12, 2018
    Publication date: May 13, 2021
    Inventors: Michelle Monje-Deisseroth, Robbie Majzner, Crystal Mackall, Christopher Mount
  • Mixed micelles
    Patent number: 9655981
    Abstract: This disclosure is directed to mixed micelle compositions for administration of e.g., therapeutic agents or imaging agents to a subject.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: May 23, 2017
    Assignees: Omeros Corporation, University of Washington through it's center For Commercialization
    Inventors: Wayne R. Gombotz, Suzie Pun, Christopher Mount, Tae Hee Kim, Benjamin W. Dulken
  • MIXED MICELLES
    Publication number: 20160228580
    Abstract: This disclosure is directed to mixed micelle compositions for administration of e.g., therapeutic agents or imaging agents to a subject.
    Type: Application
    Filed: February 19, 2016
    Publication date: August 11, 2016
    Inventors: Wayne R. Gombotz, Suzie Pun, Christopher Mount, Tae Hee Kim, Benjamin W. Dulken
  • Mixed micelles
    Patent number: 9295685
    Abstract: This disclosure is directed to mixed micelle compositions for administration of e.g., therapeutic agents or imaging agents to a subject.
    Type: Grant
    Filed: February 23, 2012
    Date of Patent: March 29, 2016
    Assignees: Omeros Corporation, University of Washington through it's center For Commercialization
    Inventors: Wayne R. Gombotz, Suzie Pun, Christopher Mount, Tae Hee Kim, Benjamin W. Dulken
  • MIXED MICELLES
    Publication number: 20120225017
    Abstract: This disclosure is directed to mixed micelle compositions for administration of e.g., therapeutic agents or imaging agents to a subject.
    Type: Application
    Filed: February 23, 2012
    Publication date: September 6, 2012
    Applicants: University of Washington through its Center for Commercialization, OMEROS CORPORATION
    Inventors: Wayne R. Gombotz, Suzie Pun, Christopher Mount, Tae Hee Kim, Benjamin W. Dulken